{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:47:59Z","timestamp":1793998079707,"version":"4.8.0"},"reference-count":46,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center Support Grant","doi-asserted-by":"publisher","award":["P30 CA16672"],"award-info":[{"award-number":["P30 CA16672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center Support Grant","doi-asserted-by":"publisher","award":["P01 CA049639"],"award-info":[{"award-number":["P01 CA049639"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2021,3,21]]},"DOI":"10.1080\/10428194.2020.1849672","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T03:25:28Z","timestamp":1607397928000},"page":"909-917","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":29,"title":["Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience"],"prefix":"10.1080","volume":"62","author":[{"given":"Rita","family":"Assi","sequence":"first","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Keating","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Pemmaraju","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-8569","authenticated-orcid":false,"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Ravandi","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-6453","authenticated-orcid":false,"given":"Gautam","family":"Borthakur","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Dahl","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Jabbour","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-1071","authenticated-orcid":false,"given":"Jorge E.","family":"Cortes","sequence":"additional","affiliation":[{"name":"Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403686"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00048-4"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2314-2"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.73"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu490"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.07.020"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211665"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.022764"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2009.0069"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24186"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90011-M"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.8.16.1888"},{"issue":"14","key":"e_1_3_5_14_1","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1242\/dev.124.14.2691","article-title":"The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites","volume":"124","author":"Soriano P.","year":"1997","unstructured":"Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development. 1997;124(14):2691\u20132700.","journal-title":"Development"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/5.5.535"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.00721"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201872"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6557"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-114900"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2014.028"},{"issue":"7","key":"e_1_3_5_21_1","first-page":"2177","article-title":"Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results","volume":"8","author":"Kantarjian HM","year":"2002","unstructured":"Kantarjian HM, Talpaz M, O'Brien S, et\u00a0al. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results. Clin Cancer Res. 2002;8(7):2177\u20132187.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-283580"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2009.09.008"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2016.1205479"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110547"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.149.5.1019"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.83107"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200411113512024"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.2574"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.128"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3356(21)00157-6"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000465191.27155.25"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099480"},{"issue":"1","key":"e_1_3_5_34_1","first-page":"1","article-title":"Management of chronic myelogenous leukemia in pregnancy","volume":"35","author":"Bhandari A","year":"2015","unstructured":"Bhandari A, Rolen K, Shah BK. Management of chronic myelogenous leukemia in pregnancy. Anticancer Res. 2015;35(1):1\u201311.","journal-title":"Anticancer Res"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2317-z"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1201571"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830380316"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1101(1999)14:1<42::AID-JCA8>3.0.CO;2-2"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb08672.x"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016340009169201"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08202.x"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<101::AID-AJH23>3.0.CO;2-D"},{"issue":"1","key":"e_1_3_5_43_1","first-page":"89","article-title":"Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report","volume":"21","author":"Baykal C","year":"2000","unstructured":"Baykal C, Zengin N, Co\u015fkun F, et\u00a0al. Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report. Eur J Gynaecol Oncol. 2000;21(1):89\u201390.","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2011.11.003"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.etp.2004.04.011"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402168"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e328352a8fe"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2020.1849672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T17:24:20Z","timestamp":1732296260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2020.1849672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3,21]]}},"alternative-id":["10.1080\/10428194.2020.1849672"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2020.1849672","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}